These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35631471)

  • 1. Liver Injury with Nintedanib: A Pharmacovigilance-Pharmacokinetic Appraisal.
    Raschi E; Fusaroli M; Gatti M; Caraceni P; Poluzzi E; De Ponti F
    Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.
    Raschi E; Poluzzi E; Koci A; Salvo F; Pariente A; Biselli M; Moretti U; Moore N; De Ponti F
    Br J Clin Pharmacol; 2015 Aug; 80(2):285-93. PubMed ID: 25689417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data.
    Wei C; Liu Y; Jiang A; Wu B
    Int J Clin Pharm; 2022 Jun; 44(3):709-716. PubMed ID: 35364753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis.
    Gatti M; Poluzzi E; De Ponti F; Raschi E
    Drug Saf; 2020 Dec; 43(12):1277-1285. PubMed ID: 32748236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the safety profiles for pirfenidone and nintedanib: a disproportionality analysis of the US food and drug administration adverse event reporting system.
    Sun X; Wang H; Zhan X; Yan Y; Chen K; An Z; Zhou H
    Front Pharmacol; 2024; 15():1256649. PubMed ID: 38860173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System.
    Antonazzo IC; Poluzzi E; Forcesi E; Riise T; Bjornevik K; Baldin E; Muratori L; De Ponti F; Raschi E
    Mult Scler; 2019 Oct; 25(12):1633-1640. PubMed ID: 30230957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.
    Brinker AD; Lyndly J; Tonning J; Moeny D; Levine JG; Avigan MI
    Drug Saf; 2013 Dec; 36(12):1169-78. PubMed ID: 24178291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury
    Rana P; Aleo MD; Wen X; Kogut S
    Acta Pharm Sin B; 2021 Dec; 11(12):3857-3868. PubMed ID: 35024312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
    Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
    Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
    Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
    Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal Detection of Potential Hepatotoxic Drugs: Case-Control Study Using Both a Spontaneous Reporting System and Electronic Medical Records.
    Akimoto H; Nagashima T; Minagawa K; Hayakawa T; Takahashi Y; Asai S
    Biol Pharm Bull; 2021; 44(10):1514-1523. PubMed ID: 34602560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
    Welch HK; Kellum JA; Kane-Gill SL
    Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced liver injury associated with pretomanid, bedaquiline, and linezolid: Insights from FAERS database analysis.
    He Q; Li Y; Liu S; Xue H; Xiang X; Wang T; Feng Z
    Br J Clin Pharmacol; 2024 Oct; ():. PubMed ID: 39419512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems.
    Raschi E; Parisotto M; Forcesi E; La Placa M; Marchesini G; De Ponti F; Poluzzi E
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1098-1107. PubMed ID: 29174026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System.
    Raschi E; Fusaroli M; Ardizzoni A; Poluzzi E; De Ponti F
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System.
    Ding L; Chen C; Yang Y; Fang J; Cao L; Liu Y
    Cardiovasc Ther; 2022; 2022():9866486. PubMed ID: 35140810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of acute kidney injury related to small-molecule protein kinase inhibitors using the FDA adverse event reporting system.
    Fan Q; Ma J; Zhang B; Li Q; Liu F; Zhao B
    Cancer Chemother Pharmacol; 2020 Nov; 86(5):655-662. PubMed ID: 33001273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS).
    Kamitaki BK; Minacapelli CD; Zhang P; Wachuku C; Gupta K; Catalano C; Rustgi V
    Epilepsy Behav; 2021 Apr; 117():107832. PubMed ID: 33626490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cataracts and statins. A disproportionality analysis using data from VigiBase.
    Macías Saint-Gerons D; Bosco Cortez F; Jiménez López G; Castro JL; Tabarés-Seisdedos R
    Regul Toxicol Pharmacol; 2019 Dec; 109():104509. PubMed ID: 31669197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database.
    Zhou ZX; Yin XD; Zhang Y; Shao QH; Mao XY; Hu WJ; Shen YL; Zhao B; Li ZL
    Front Pharmacol; 2022; 13():891336. PubMed ID: 35571077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.